BPC-157: The Gut-Healing Peptide Your Doctor Won’t Mention
There’s a peptide with over 100 published studies — most of them showing remarkable gut healing, tendon repair, and organ protection. It’s been researched since the 1990s. It has a solid safety profile in every study conducted.
And your doctor has probably never heard of it.
It’s called BPC-157, and the reason it’s not on your radar has nothing to do with the science. It has to do with who funds drug research — and what happens when a peptide can’t be patented.
What is BPC-157?
BPC stands for “Body Protection Compound.” It’s a pentadecapeptide — a chain of 15 amino acids — that was originally isolated from human gastric juice. Yes, stomach acid.
Your body naturally produces a version of this peptide. It’s part of how your gut protects and repairs itself. BPC-157 is the synthetic version of that natural compound, and researchers have been studying it for over 30 years.
The key research comes from a team led by Predrag Sikirić at the University of Zagreb in Croatia. They’ve published more than 100 papers on BPC-157, covering everything from gut ulcers to tendon healing to brain protection. The 2023 review in Pharmaceuticals summarizes decades of findings: BPC-157 consistently promotes healing across multiple organ systems.
What does the research show?
Gut healing
This is where BPC-157 shines. The gut is where it was discovered, and the gut is where the strongest evidence exists.
BPC-157 promotes healing of intestinal ulcers, protects against NSAID damage (ibuprofen, aspirin, naproxen), and repairs intestinal barrier function — what people commonly call “leaky gut.”
A 2024 study in Inflammopharmacology showed that BPC-157 protected against multiorgan failure caused by vascular occlusion. A 2020 review in Gut and Liver documented its consistent cytoprotective effects — meaning it protects cells from damage.
The mechanism is specific: BPC-157 interacts with the nitric oxide (NO) system, promotes angiogenesis (new blood vessel formation), and modulates dopaminergic and serotonergic pathways. It’s not just covering up symptoms — it’s actively supporting tissue repair.
Tendon and muscle healing
A 2019 review in Cell and Tissue Research found that BPC-157 accelerated musculoskeletal soft tissue healing. A 2011 study in Journal of Applied Physiology showed it promoted tendon outgrowth, cell survival, and cell migration during tendon repair.
A 2021 review in Frontiers in Pharmacology confirmed: BPC-157 consistently promotes wound healing across multiple tissue types.
For anyone dealing with nagging tendon injuries, chronic gut issues, or slow healing — this is the kind of research that gets your attention.
NSAID protection
This one is huge. NSAIDs (ibuprofen, naproxen, aspirin) are among the most commonly used drugs. They’re also one of the biggest causes of gut damage.
A 2013 study showed that BPC-157 counteracted toxicity from NSAIDs across multiple organ systems. If you take ibuprofen regularly for pain or inflammation, BPC-157 may protect your gut from the damage those drugs cause.
The elephant in the room: animal studies
Here’s where I have to be honest with you.
Most of the BPC-157 research is in animals — primarily rats and mice. The human clinical trial data is extremely limited. A 2026 narrative review titled “Regeneration or Risk?” highlighted this gap directly: the preclinical evidence is compelling, but robust human trials are still lacking.
Does this mean BPC-157 doesn’t work in humans? No. It means we don’t have the same level of evidence we have for, say, omega-3s or magnesium.
The animal studies are remarkably consistent — BPC-157 works across species, across organ systems, across injury models. That consistency is unusual and suggests the effects are real. But “suggests” is not “proves.”
Why your doctor won’t mention it
Three reasons:
No pharma funding. BPC-157 is a naturally-derived peptide. It can’t be easily patented. Without patent protection, pharmaceutical companies have no financial incentive to fund expensive human clinical trials. No trials = no FDA approval = no drug reps pushing it to doctors.
Not in medical school curricula. Doctors learn about drugs that are FDA-approved or in active clinical development. BPC-157 doesn’t fall into either category, so it’s not taught.
The supplement gray zone. BPC-157 exists in a regulatory gray area. It’s not FDA-approved as a drug, but it’s available as a “research peptide.” Doctors are trained to recommend FDA-approved treatments, not experimental peptides purchased online.
This doesn’t mean your doctor is wrong. It means the system isn’t set up to surface promising compounds that can’t be monetized by pharma.
How people actually use BPC-157
Since BPC-157 isn’t available as a standard supplement, people typically access it through:
- Research peptide vendors — sold for “research purposes only”
- Compounding pharmacies — some doctors prescribe it through compounding pharmacies (ask your functional medicine doctor)
- Oral capsules — some companies have started selling oral BPC-157, though oral bioavailability is debated
The most common dosing protocol in the research community is 250-500 mcg taken twice daily. Some people use injectable forms for more targeted delivery.
Important: Talk to a healthcare provider before using BPC-157, especially if you’re pregnant, nursing, or on medications. The safety profile in animal studies is excellent, but human safety data is limited.
The bottom line
BPC-157 is one of the most researched peptides in regenerative medicine. Over 100 published studies show consistent gut healing, tendon repair, and organ protection. The mechanism is well-understood. The safety profile in animal studies is clean.
But it’s not FDA-approved. Most of the evidence is from animal studies. And it exists in a regulatory gray zone that makes it invisible to mainstream medicine.
If you’re dealing with gut issues, chronic inflammation, or slow-healing injuries, BPC-157 is worth researching further — and worth discussing with a functional medicine doctor who’s familiar with peptides.
The science is there. The system just hasn’t caught up.
Coming soon: Which peptides actually work? A practical guide to peptide therapy for inflammation, gut health, and recovery.
Note: BPC-157 is not available as an Amazon supplement. It’s classified as a research peptide. If you’re interested in trying it, consult a functional medicine doctor who can prescribe it through a compounding pharmacy. Find a functional medicine practitioner near you.
FTC Disclosure: This article contains no affiliate links. BPC-157 is not available through standard supplement retailers. All research cited is from peer-reviewed PubMed studies.
References
- Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. Pharmaceuticals. 2023;16(5):676.
- Sikiric P, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857-865.
- Vukojevic J, et al. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022;17(3):482-483.
- Sikiric P, et al. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. Inflammopharmacology. 2024;32(5):3027-3046.
- Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 and Selye’s Stress Coping Response. Gut Liver. 2020;14(2):153-167.
- McGuire FP, et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025;18(12):567-578.
- Sikiric P, et al. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2013;19(1):76-83.
- Gwyer D, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.
- Seiwerth S, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. 2021;12:627533.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011;110(3):774-780.